Literature DB >> 21207051

Structural gray and white matter changes in patients with HIV.

Michael Küper1, K Rabe, S Esser, E R Gizewski, I W Husstedt, M Maschke, M Obermann.   

Abstract

In this cross-sectional study we used magnetic resonance imaging (MRI)-based voxel based morphometry (VBM) in a sample of HIV positive patients to detect structural gray and white matter changes. Forty-eight HIV positive subjects with (n = 28) or without (n = 20) cognitive deficits (mean age 48.5 ± 9.6 years) and 48 age- and sex-matched HIV negative controls underwent MRI for VBM analyses. Clinical testing in HIV patients included the HIV dementia scale (HDS), Unified Parkinson's Disease Rating Scale (UPDRS) and the grooved pegboard test. Comparing controls with HIV positive patients with cognitive dysfunction (n = 28) VBM showed gray matter decrease in the anterior cingulate and temporal cortices along with white matter reduction in the midbrain region. These changes were more prominent with increasing cognitive decline, when assigning HIV patients to three cognitive groups (not impaired, mildly impaired, overtly impaired) based on performance in the HIV dementia scale. Regression analysis including all HIV positive patients with available data revealed that prefrontal gray matter atrophy in HIV was associated with longer disease duration (n = 48), while motor dysfunction (n = 48) was associated with basal ganglia gray matter atrophy. Lower CD4 cell count (n = 47) correlated with decrease of occipital gray matter. Our results provide evidence for atrophy of nigro-striatal and fronto-striatal circuits in HIV. This pattern of atrophy is consistent with motor dysfunction and dysexecutive syndrome found in HIV patients with HIV-associated neurocognitive disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207051     DOI: 10.1007/s00415-010-5883-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Linear increases in BOLD response associated with increasing proportion of incongruent trials across time in a colour Stroop task.

Authors:  Rachel L C Mitchell
Journal:  Exp Brain Res       Date:  2010-03-25       Impact factor: 1.972

2.  The emergence of explicit memory during learning.

Authors:  Michael Rose; Hilde Haider; Christian Büchel
Journal:  Cereb Cortex       Date:  2010-03-01       Impact factor: 5.357

3.  A voxel-based morphometric study of ageing in 465 normal adult human brains.

Authors:  C D Good; I S Johnsrude; J Ashburner; R N Henson; K J Friston; R S Frackowiak
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

4.  3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry.

Authors:  Ming-Chang Chiang; Rebecca A Dutton; Kiralee M Hayashi; Oscar L Lopez; Howard J Aizenstein; Arthur W Toga; James T Becker; Paul M Thompson
Journal:  Neuroimage       Date:  2006-10-10       Impact factor: 6.556

5.  Verbal fluency in HIV infection: a meta-analytic review.

Authors:  Jennifer E Iudicello; Steven Paul Woods; Thomas D Parsons; Lisa M Moran; Catherine L Carey; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2007-01       Impact factor: 2.892

6.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.

Authors:  Adarsh M Kumar; J B Fernandez; Elyse J Singer; Deborah Commins; Drenna Waldrop-Valverde; Raymond L Ownby; Mahendra Kumar
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

7.  Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy.

Authors:  L A Cysique; F Vaida; S Letendre; S Gibson; M Cherner; S P Woods; J A McCutchan; R K Heaton; R J Ellis
Journal:  Neurology       Date:  2009-05-27       Impact factor: 9.910

8.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

9.  Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.

Authors:  Mark Obermann; M Küper; O Kastrup; O Yaldizli; S Esser; J Thiermann; E Koutsilieri; G Arendt; H-C Diener; M Maschke
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

10.  Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain.

Authors:  B M Ances; D Sisti; F Vaida; C L Liang; O Leontiev; J E Perthen; R B Buxton; D Benson; D M Smith; S J Little; D D Richman; D J Moore; R J Ellis
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

View more
  77 in total

1.  Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIV infection.

Authors:  C Zucchella; E Sinforiani; E Tavazzi; S Del Bue; S Novati; R Maserati; M Ceroni; S Bastianello; L Minoli; P Ferrante; E Marchioni
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

2.  Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Erica Weber; Alexandra S Rooney; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-02-02       Impact factor: 2.475

3.  Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.

Authors:  Angela Matinella; M Lanzafame; M A Bonometti; A Gajofatto; E Concia; S Vento; S Monaco; S Ferrari
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

4.  Resting-state neural signatures of depressive symptoms in acute HIV.

Authors:  Carissa L Philippi; Leah Reyna; Laura Nedderman; Phillip Chan; Vishal Samboju; Kevin Chang; Nittaya Phanuphak; Nisakorn Ratnaratorn; Joanna Hellmuth; Khunthalee Benjapornpong; Netsiri Dumrongpisutikul; Mantana Pothisri; Merlin L Robb; Jintanat Ananworanich; Serena Spudich; Victor Valcour; Robert Paul
Journal:  J Neurovirol       Date:  2020-01-27       Impact factor: 2.643

5.  Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life.

Authors:  Savanna M Tierney; Steven Paul Woods; David Sheppard; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-12-10       Impact factor: 2.643

6.  Subcortical shape and volume abnormalities in an elderly HIV+ cohort.

Authors:  Benjamin S C Wade; Victor Valcour; Edgar Busovaca; Pardis Esmaeili-Firidouni; Shantanu H Joshi; Yalin Wang; Paul M Thompson
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-17

7.  Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.

Authors:  Adolf Pfefferbaum; David A Rogosa; Margaret J Rosenbloom; Weiwei Chu; Stephanie A Sassoon; Carol A Kemper; Stanley Deresinski; Torsten Rohlfing; Natalie M Zahr; Edith V Sullivan
Journal:  Neurobiol Aging       Date:  2014-01-13       Impact factor: 4.673

8.  Association of HIV serostatus and metabolic syndrome with neurobehavioral disturbances.

Authors:  Caitlin N Pope; Jessica L Montoya; Elizabeth Vasquez; Josué Pérez-Santiago; Ronald Ellis; J Allen McCutchan; Dilip V Jeste; David J Moore; María J Marquine
Journal:  J Neurovirol       Date:  2020-07-30       Impact factor: 2.643

9.  Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.

Authors:  Deborrah Castillo; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-02       Impact factor: 4.147

10.  Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.

Authors:  Anika Guha; Matthew R Brier; Mario Ortega; Elizabeth Westerhaus; Brittany Nelson; Beau M Ances
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.